TESTBANK j1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
j1 j1 j1 j1 j1 j1 j1
Author: Teri Moser Woo and Wendy L. Wright
j1 j1 j1 j1 j1 j1 j1
, TABLE OF CONTENT j1 j1
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ......................................................................... 4
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 2. Review of Basic Principles of Pharmacology ........................................................................................ 5
j1 j1 j1 j1 j1 j1 j1
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
j1 j1 j1 j1
Chapter 4. Legal and Professional Issues in Prescribing ....................................................................................... 14
j1 j1 j1 j1 j1 j1 j1
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
j1 j1 j1 j1
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................... 19
j1 j1 j1 j1 j1
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
j1 j1 j1 j1
Chapter 8. Herbal Therapies ................................................................................................................................. 28
j1 j1 j1
Chapter 9. Cannabis ............................................................................................................................................. 31
j1 j1
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
j1 j1
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................. 38
j1 j1 j1 j1 j1 j1 j1
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................... 45
j1 j1 j1 j1 j1 j1 j1
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems.................................................................... 53
j1 j1 j1 j1 j1 j1 j1 j1
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................... 61
j1 j1 j1 j1 j1 j1
Chapter 15. Drugs Affecting the Hematological System ...................................................................................... 65
j1 j1 j1 j1 j1 j1
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................. 69
j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................... 75
j1 j1 j1 j1 j1 j1 j1
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................... 77
j1 j1 j1 j1 j1 j1
Chapter19. Drugs Affecting the EndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ....................... 80
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................ 83
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 21. Drugs Affecting the Reproductive System ........................................................................................ 86
j1 j1 j1 j1 j1 j1
Chapter 22. Drugs Affecting the Bones and Joints................................................................................................ 92
j1 j1 j1 j1 j1 j1 j1
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
j1 j1 j1 j1 j1 j1
Chapter 24. Drugs Used to Treat Bacterial Infections ......................................................................................... 101
j1 j1 j1 j1 j1 j1 j1
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................... 105
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................. 108
j1 j1 j1 j1 j1 j1 j1
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ..................................................................................... 111
j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 28. Anemia ........................................................................................................................................... 113
j1 j1
Chapter 29. Anxiety and Depression .................................................................................................................. 116
j1 j1 j1 j1
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
j1 j1 j1 j1
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
j1 j1 j1 j1
Chapter 32. Chronic Obstructive Pulmonary Disease ......................................................................................... 125
j1 j1 j1 j1 j1
Chapter 33. Contraception ................................................................................................................................. 127
j1 j1
Chapter 34. COVID-19: Acute and Chronic ....................................................................................................... 130
j1 j1 j1 j1 j1
Chapter 35. Dermatological Conditions ............................................................................................................. 134
j1 j1 j1
Chapter 36. Diabetes Management .................................................................................................................... 138
j1 j1 j1
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ........................................................................ 146
j1 j1 j1 j1 j1 j1 j1
Chapter 38. Headaches....................................................................................................................................... 149
j1 j1
Chapter 39. Heart Failure ................................................................................................................................... 153
j1 j1 j1
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................. 158
j1 j1 j1 j1 j1 j1 j1
Chapter 41. Menopausal Hormone Therapy....................................................................................................... 161
j1 j1 j1 j1
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
j1 j1
Chapter 43. Hypertension................................................................................................................................... 169
j1 j1
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
j1 j1 j1 j1
Chapter 45. Obesity ........................................................................................................................................... 177
j1 j1
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................... 181
j1 j1 j1 j1 j1 j1 j1
Chapter 47. Pneumonia ...................................................................................................................................... 185
j1 j1
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................. 187
j1 j1 j1 j1 j1 j1
Chapter 49. Substance Use Disorders ................................................................................................................. 190
j1 j1 j1 j1
Chapter 50. Tuberculosis ................................................................................................................................... 195
j1 j1
Chapter51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............... 197
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 52. Urinary Tract Infections .................................................................................................................. 200
j1 j1 j1 j1
Chapter 53. Women as Patients .......................................................................................................................... 203
j1 j1 j1 j1
Chapter 54. Men as Patients ............................................................................................................................... 207
j1 j1 j1 j1
Chapter 55. Pediatric Patients............................................................................................................................. 209
j1 j1 j1
Chapter 57. Geriatric Patients............................................................................................................................. 213
j1 j1 j1
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e j1 j1 j1 j1 Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
MULTIPLE CHOICE j1
1. Nurse practitioner prescriptive authority is regulated by:
j1 j1 j1 j1 j1 j1
A. The National Council of State Boards of Nursing
j1 j1 j1 j1 j1 j1 j1
B. The U.S. Drug Enforcement Administrationj1 j1 j1 j1
C. The State Board of Nursing for each state
j1 j1 j1 j1 j1 j1 j1
D. The State Board of Pharmacy j1 j1 j1 j1
ANS: j 1 C PTS: j 1 j 1 1
2. Thebenefits to thepatient ofhaving an advanced practice registered nurse (APRN) prescriber
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
j1 include:
A. Nurses know more about pharmacology than other prescribers because they takeit
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
both in their basic nursing program and in their APRN program.
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
B. Nurses care for thepatient from a holistic approach and includethe patient in
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
decision-making regarding their care.
j1 j1 j1 j1
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
D. APRNs areableto prescribeindependently in all states, whereas aphysician’s
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
assistant needs to have a physician supervising their practice.
j1 j1 j1 j1 j1 j1 j1 j1 j1
ANS: j 1 B PTS: j 1 j 1 1
3. Clinical judgment in prescribing includes:j1 j1 j1 j1
A. Factoring in the cost to the patient of the medication prescribed j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
B. Always prescribing the newest medication available for the diseaseprocess
j1 j1 j1 j1 j1 j1 j1 j1 j1
C. Handing out drug samples to poor patients j1 j1 j1 j1 j1 j1
D. Prescribing all generic medications to cutcosts j1 j1 j1 j1 j1 j1
ANS: j 1 A PTS: j 1 j 1 1
4. The process for choosing an effective drug for a disorder includes:
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
A. Asking the patient what drug they think would work best for them
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
B. Consulting nationally recognized guidelines for diseasemanagement j1 j1 j1 j1 j1 j1
C. Prescribing medications that are available as samples before writing a prescription j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
D. Following U.S. Drug Enforcement Administration guidelines forprescribing j1 j1 j1 j1 j1 j1 j1
ANS: j 1 B PTS: j 1 j 1 1
5. Nonintentional nonadherence of drug therapy may occur due to: j1 j1 j1 j1 j1 j1 j1 j1
A. Belief that medication does not work j1 j1 j1 j1 j1
B. Adverse drug reactions j1 j1
C. Chronic conditions that require dailytherapy j1 j1 j1 j1 j1
D. Forgetfulness ordistraction j1 j1
ANS: j 1 D PTS: j 1 j 1 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
j1 j1 j1 j1 j1 j1 j1
Author: Teri Moser Woo and Wendy L. Wright
j1 j1 j1 j1 j1 j1 j1
, TABLE OF CONTENT j1 j1
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ......................................................................... 4
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 2. Review of Basic Principles of Pharmacology ........................................................................................ 5
j1 j1 j1 j1 j1 j1 j1
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
j1 j1 j1 j1
Chapter 4. Legal and Professional Issues in Prescribing ....................................................................................... 14
j1 j1 j1 j1 j1 j1 j1
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
j1 j1 j1 j1
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................... 19
j1 j1 j1 j1 j1
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
j1 j1 j1 j1
Chapter 8. Herbal Therapies ................................................................................................................................. 28
j1 j1 j1
Chapter 9. Cannabis ............................................................................................................................................. 31
j1 j1
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
j1 j1
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................. 38
j1 j1 j1 j1 j1 j1 j1
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................... 45
j1 j1 j1 j1 j1 j1 j1
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems.................................................................... 53
j1 j1 j1 j1 j1 j1 j1 j1
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................... 61
j1 j1 j1 j1 j1 j1
Chapter 15. Drugs Affecting the Hematological System ...................................................................................... 65
j1 j1 j1 j1 j1 j1
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................. 69
j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................... 75
j1 j1 j1 j1 j1 j1 j1
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................... 77
j1 j1 j1 j1 j1 j1
Chapter19. Drugs Affecting the EndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ....................... 80
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................ 83
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 21. Drugs Affecting the Reproductive System ........................................................................................ 86
j1 j1 j1 j1 j1 j1
Chapter 22. Drugs Affecting the Bones and Joints................................................................................................ 92
j1 j1 j1 j1 j1 j1 j1
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
j1 j1 j1 j1 j1 j1
Chapter 24. Drugs Used to Treat Bacterial Infections ......................................................................................... 101
j1 j1 j1 j1 j1 j1 j1
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................... 105
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................. 108
j1 j1 j1 j1 j1 j1 j1
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ..................................................................................... 111
j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 28. Anemia ........................................................................................................................................... 113
j1 j1
Chapter 29. Anxiety and Depression .................................................................................................................. 116
j1 j1 j1 j1
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
j1 j1 j1 j1
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
j1 j1 j1 j1
Chapter 32. Chronic Obstructive Pulmonary Disease ......................................................................................... 125
j1 j1 j1 j1 j1
Chapter 33. Contraception ................................................................................................................................. 127
j1 j1
Chapter 34. COVID-19: Acute and Chronic ....................................................................................................... 130
j1 j1 j1 j1 j1
Chapter 35. Dermatological Conditions ............................................................................................................. 134
j1 j1 j1
Chapter 36. Diabetes Management .................................................................................................................... 138
j1 j1 j1
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ........................................................................ 146
j1 j1 j1 j1 j1 j1 j1
Chapter 38. Headaches....................................................................................................................................... 149
j1 j1
Chapter 39. Heart Failure ................................................................................................................................... 153
j1 j1 j1
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................. 158
j1 j1 j1 j1 j1 j1 j1
Chapter 41. Menopausal Hormone Therapy....................................................................................................... 161
j1 j1 j1 j1
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
j1 j1
Chapter 43. Hypertension................................................................................................................................... 169
j1 j1
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
j1 j1 j1 j1
Chapter 45. Obesity ........................................................................................................................................... 177
j1 j1
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................... 181
j1 j1 j1 j1 j1 j1 j1
Chapter 47. Pneumonia ...................................................................................................................................... 185
j1 j1
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................. 187
j1 j1 j1 j1 j1 j1
Chapter 49. Substance Use Disorders ................................................................................................................. 190
j1 j1 j1 j1
Chapter 50. Tuberculosis ................................................................................................................................... 195
j1 j1
Chapter51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............... 197
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
Chapter 52. Urinary Tract Infections .................................................................................................................. 200
j1 j1 j1 j1
Chapter 53. Women as Patients .......................................................................................................................... 203
j1 j1 j1 j1
Chapter 54. Men as Patients ............................................................................................................................... 207
j1 j1 j1 j1
Chapter 55. Pediatric Patients............................................................................................................................. 209
j1 j1 j1
Chapter 57. Geriatric Patients............................................................................................................................. 213
j1 j1 j1
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e j1 j1 j1 j1 Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
MULTIPLE CHOICE j1
1. Nurse practitioner prescriptive authority is regulated by:
j1 j1 j1 j1 j1 j1
A. The National Council of State Boards of Nursing
j1 j1 j1 j1 j1 j1 j1
B. The U.S. Drug Enforcement Administrationj1 j1 j1 j1
C. The State Board of Nursing for each state
j1 j1 j1 j1 j1 j1 j1
D. The State Board of Pharmacy j1 j1 j1 j1
ANS: j 1 C PTS: j 1 j 1 1
2. Thebenefits to thepatient ofhaving an advanced practice registered nurse (APRN) prescriber
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
j1 include:
A. Nurses know more about pharmacology than other prescribers because they takeit
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
both in their basic nursing program and in their APRN program.
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
B. Nurses care for thepatient from a holistic approach and includethe patient in
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
decision-making regarding their care.
j1 j1 j1 j1
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
D. APRNs areableto prescribeindependently in all states, whereas aphysician’s
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
assistant needs to have a physician supervising their practice.
j1 j1 j1 j1 j1 j1 j1 j1 j1
ANS: j 1 B PTS: j 1 j 1 1
3. Clinical judgment in prescribing includes:j1 j1 j1 j1
A. Factoring in the cost to the patient of the medication prescribed j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
B. Always prescribing the newest medication available for the diseaseprocess
j1 j1 j1 j1 j1 j1 j1 j1 j1
C. Handing out drug samples to poor patients j1 j1 j1 j1 j1 j1
D. Prescribing all generic medications to cutcosts j1 j1 j1 j1 j1 j1
ANS: j 1 A PTS: j 1 j 1 1
4. The process for choosing an effective drug for a disorder includes:
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
A. Asking the patient what drug they think would work best for them
j1 j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
B. Consulting nationally recognized guidelines for diseasemanagement j1 j1 j1 j1 j1 j1
C. Prescribing medications that are available as samples before writing a prescription j1 j1 j1 j1 j1 j1 j1 j1 j1 j1
D. Following U.S. Drug Enforcement Administration guidelines forprescribing j1 j1 j1 j1 j1 j1 j1
ANS: j 1 B PTS: j 1 j 1 1
5. Nonintentional nonadherence of drug therapy may occur due to: j1 j1 j1 j1 j1 j1 j1 j1
A. Belief that medication does not work j1 j1 j1 j1 j1
B. Adverse drug reactions j1 j1
C. Chronic conditions that require dailytherapy j1 j1 j1 j1 j1
D. Forgetfulness ordistraction j1 j1
ANS: j 1 D PTS: j 1 j 1 1
